Extended deadline: Please be informed project submission for the "Gilead Cell Therapy Grants 2024" is still open until 01 January 2024, midnight!
The Belgian Hematology Society (BHS), with the support of an unrestricted grant from Gilead Sciences and Kite, a Gilead company, has the pleasure to announce one grant to support research in the field of cellular therapies in hematological disease.
Researchers working in hematology are invited to submit their projects and apply for the Gilead Cell Therapy Grants. All information on rules and regulations are available on the homepage, as is the application form.
The extended deadline for submission is on Monday, 01 January 2024, at midnight CET.
The jury will select one winning project based on their innovative character, which will be awarded with EUR 25.000. The award ceremony will take place at the 39th BHS General Annual Meeting, February 2-3, 2024.
We are looking forward to receiving outstanding projects that can advance the outcomes of hematological diseases through cellular therapies.
Sincerely,
Prof. Marc André, President of the BHS